We invite you to explore the links below to find out more about commercial litigation, intellectual property, mesothelioma cancer, pharmaceutical (drug) liability, product liability, toxic exposures and wrongful death!
|
Syndicate
FDA: Medical Watch
FDA MedWatch Safety Alerts
Updated: 2 hours 23 min ago
Cepheid Xpert MRSA/SA Blood Culture Assay for Use with the GeneXpert Dx System: Class I Recall
The firm received increasing numbers of complaints for false negative MRSA results. False negative could result in incorrect treatment or delay of care for patients with MRSA infection.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
LIFEPAK 20 and LIFEPAK 20e External Defibrillator/Monitors by Physio-Control Inc.: Class I Recall Due To Power Supply Failure
A power supply assembly failure can result in the inability to deliver defibrillation therapy.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Mylotarg (gemtuzumab ozogamicin): Market Withdrawal
Drug failed to demonstrate clinical benefit to patients enrolled in trials.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Magic Power Coffee: Undeclared Drug Ingredient
Product marketed as a dietary supplement for sexual enhancement contains the drug ingredient hydroxythiohomosildenafil, a chemical that may interact with prescription nitrates, and cause dangerously low blood pressure.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Tamiflu: Counterfeit Product Sold on Internet
Potentially harmful product represented as “Generic Tamiflu”- tests revealed product does not contain oseltamivir, but cloxacillin, an antibiotic.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Vitamin D Supplement Products: Medication Use Error
Some liquid Vitamin D supplement products are sold with droppers that could allow parents to accidentally give harmful amounts of Vitamin D to their infant.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Benicar (olmesartan): Ongoing Safety Review
FDA evaluating data in which type 2 diabetes patients taking Benicar had a higher rate of death from cardiovascular cause compared to placebo. FDA has not concluded that Benicar increases the risk of death.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Hospira Brand Liposyn and Propofol: Recall
Injectable products may contain particulate matter.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Defibtech DBP-2800 Battery Packs used in Lifeline AED and ReviveR AED: Recall
AED may falsely detect an error condition during charging for a shock, then cancel charge and not provide therapy, when used with an affected battery pack.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Counterfeit Polypropylene Surgical Mesh: Initial Communication
[UPDATED 06/08/2010] Recall classified as Class I. Various sizes of counterfeit flat sheets of polypropylene surgical mesh marketed in the U.S. labeled with the C. R. Bard/Davol brand name.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
GammaGard Liquid, Immune Globulin Intravenous (Human)
Market withdrawal due to an increased number of adverse event reports of allergic reactions associated with two lots.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements
[UPDATED 06/03/2010] Drug labels now contain updated recommendations.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Intravenous Medications Manufactured by Claris: Recall due to contamination of products
Products sold under the Claris, Sagent Pharmaceuticals, Pfizer, and West-Ward Pharmaceuticals labels. Reports of floating matter in intravenous bags of metronidazole and ondansetron. Foreign matter should not be present in a sterile injectable product.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
PediaCare Children's Products [Blacksmith Brand]: Recall of four products
The four products were manufactured at a plant cited by FDA for deficiencies in Good Manufacturing Practices. Posted 05/30/2010
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Arrow Brand Medicated Oil and Embrocation: Consumer Warning, Product Considered Toxic
Product contains substances which are poisonous when ingested or applied to large areas of the body.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Hylenex recombinant (hyaluronidase human injection): Recall
Voluntary recall of all manufactured lots has been initiated as a precautionary measure due to instances of particulate matter observed in a limited number of vials during routine stability testing.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Orlistat (marketed as Alli and Xenical): Labeling Change
Revised labeling to include cases of severe liver injury.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Proton Pump Inhibitors (PPI): Class Labeling Change
Possible increased risk of fractures of the hip, wrist, and spine.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
Ultram (tramadol hydrochloride), Ultracet (tramadol hydrochloride/acetaminophen): Label Change
Risk of overdosage or suicide for patients who are addiction-prone, taking tranquilizers or antidepressant drugs.
Categories: NEWS: U.S. Food and Drug Administration (FDA)
- « first
- ‹ previous
- 1
- 2
- 3